Skip to content
Search

Latest Stories

Alliance Healthcare pledges to reduce single-use plastic by 60 per cent in three years

Alliance Healthcare UK has pledged to reduce the use of single-use secondary plastic by 60 per cent within three years.

Measures undertaken by the company to reduce its carbon footprint, which were initiated last year, have carried on despite the challenges thrown by the Covid-19 pandemic.


Alliance Healthcare UK recently started to roll out new reusable tote bins to replace plastic bags and cardboard packaging to its Health and Beauty customers.

Work being carried out across the company, as part of its 'Getting drastic with plastic' campaign, includes removal of invoice bags, switching to paper bubble wrap and investment in reusable totes, the company said on Tuesday (Oct 27).

“We recognise that as an industry leader we must pioneer the way in reducing our impact on the environment, managing director Julian Mount said. "Our three year plan will entail an ambitious 35 per cent reduction of single-use plastic secondary packaging by September 2021.”

Aiming to reduce the overall use of single-use plastic by 60 per cent by September 2022, three years from when the initiative started in 2019, Alliance Healthcare UK has already saved over 39 tonnes of single-use plastic items. By the close of the next fiscal-year the aim is to save a total of 131 tonnes, the company added.

“Every year, over two million units of single-use plastic bags and cardboard boxes will be removed from our operations, considerably lessening Alliance Healthcare’s carbon footprint,” said Jon Cornforth, the national environment health and safety manager.

Several businesses in the UK have increased their push on cutting plastic pollution since a 2018 David Attenborough series, Blue Planet II, drew wider attention to the problem.

Community pharmacies have been banned from supplying plastic straws and plastic stemmed cotton buds to customers in England after the latest environmental protection regulations came into force on October 1, 2020.

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less